NYSE:MET - MetLife Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $51.73
  • Forecasted Upside: -10.20 %
  • Number of Analysts: 12
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 10 Buy Ratings
  • 0 Strong Buy Ratings
$57.60
▼ -0.66 (-1.13%)
1 month | 3 months | 12 months
Get New MetLife Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MET and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MET

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$51.73
▼ -10.20% Downside Potential
This price target is based on 12 analysts offering 12 month price targets for MetLife in the last 3 months. The average price target is $51.73, with a high forecast of $63.00 and a low forecast of $32.00. The average price target represents a -10.20% upside from the last price of $57.60.
Buy
The current consensus among 12 contributing investment analysts is to buy stock in MetLife. This rating has held steady since February 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 0 sell ratings
9/5/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 5 hold ratings
  • 0 sell ratings
12/4/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 5 hold ratings
  • 0 sell ratings
3/3/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/1/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings
8/30/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/28/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/27/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/25/2021Morgan StanleyBoost Price TargetOverweight$58.00 ➝ $60.00Medium
i
2/23/2021BarclaysBoost Price TargetOverweight$53.00 ➝ $60.00Low
i
2/17/2021ArgusBoost Price TargetPositive ➝ Buy$53.00 ➝ $63.00Low
i
2/4/2021Morgan StanleyBoost Price TargetOverweight$57.00 ➝ $58.00High
i
1/15/2021Morgan StanleyBoost Price TargetOverweight$53.00 ➝ $57.00Low
i
1/6/2021Piper SandlerUpgradeNeutral ➝ Overweight$45.00 ➝ $52.00N/A
i
12/13/2020BarclaysReiterated RatingBuy$53.00Medium
i
12/8/2020Smith Barney CitigroupUpgradeNeutral ➝ Buy$39.00 ➝ $55.00Low
i
12/8/2020Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellUpgradeNeutral ➝ Buy$39.00 ➝ $55.00Medium
i
12/4/2020The Goldman Sachs GroupInitiated CoverageNeutral$48.00Low
i
11/18/2020Morgan StanleyBoost Price TargetOverweight$49.00 ➝ $53.00Medium
i
11/17/2020Credit Suisse GroupBoost Price TargetOutperform ➝ Positive$46.00 ➝ $55.00Low
i
11/17/2020BarclaysInitiated CoverageOverweight$52.00Low
i
11/5/2020Morgan StanleyBoost Price TargetOverweight$47.00 ➝ $49.00High
i
10/6/2020Morgan StanleyBoost Price TargetOverweight$46.00 ➝ $47.00Medium
i
9/18/2020Credit Suisse GroupReiterated RatingBuy$46.00Low
i
8/20/2020Morgan StanleyBoost Price TargetOverweight$44.00 ➝ $46.00Low
i
8/19/2020ArgusReiterated RatingBuyLow
i
8/6/2020Wells Fargo & CompanyReiterated RatingBuy$45.00Medium
i
7/6/2020Morgan StanleyBoost Price TargetOverweight$40.00 ➝ $44.00Low
i
6/1/2020Bank of AmericaInitiated CoverageBuyLow
i
5/8/2020Royal Bank of CanadaBoost Price TargetOutperform$42.00 ➝ $44.00Medium
i
5/7/2020Morgan StanleyBoost Price TargetOverweight$38.00 ➝ $40.00Medium
i
Rating by Nigel Dally at Morgan Stanley
4/27/2020Credit Suisse GroupLower Price TargetOutperform$60.00 ➝ $46.00Low
i
4/3/2020Piper SandlerLower Price TargetNeutral$38.00 ➝ $33.00Medium
i
4/1/2020Wells Fargo & CompanyLower Price TargetOverweight$59.00 ➝ $44.00Medium
i
3/20/2020Royal Bank of CanadaLower Price Target$57.00 ➝ $42.00High
i
3/17/2020Morgan StanleyLower Price TargetOverweight$60.00 ➝ $38.00High
i
Rating by Nigel Dally at Morgan Stanley
3/16/2020CitigroupUpgradeSell ➝ Neutral$46.00 ➝ $32.00Medium
i
3/10/2020Piper SandlerLower Price TargetNeutral$51.00 ➝ $38.00Medium
i
2/27/2020Piper SandlerLower Price TargetNeutral$55.00 ➝ $51.00High
i
2/9/2020Royal Bank of CanadaReiterated RatingBuy$57.00Low
i
2/3/2020Credit Suisse GroupLower Price TargetOutperform$63.00 ➝ $60.00Low
i
1/7/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$55.00 ➝ $60.00Low
i
1/6/2020Wells Fargo & CompanyReiterated RatingBuyN/A
i
Rating by John Hall at Wells Fargo & Company
12/9/2019Wells Fargo & CompanyReiterated RatingBuyLow
i
Rating by John Hall at Wells Fargo & Company
10/15/2019B. RileyReiterated RatingNeutralMedium
i
Rating by R. Binner at B. Riley
10/10/2019UBS GroupBoost Price TargetNeutral$46.00 ➝ $47.00Low
i
9/13/2019CitigroupLower Price TargetSell$42.00 ➝ $41.00Low
i
Rating by Suneet Kamath at Citigroup Inc.
8/20/2019Morgan StanleyLower Price TargetEqual Weight$54.00 ➝ $53.00Low
i
7/11/2019Wells Fargo & CompanyBoost Price TargetOutperform$55.00 ➝ $57.00Low
i
Rating by John Hall at Wells Fargo & Company
7/10/2019Morgan StanleyBoost Price TargetEqual Weight$52.00 ➝ $53.00Low
i
6/5/2019Wells Fargo & CompanyReiterated RatingBuy$55.00Low
i
Rating by Elyse Greenspan at Wells Fargo & Company
5/23/2019CitigroupSet Price TargetSell$42.00Low
i
Rating by Suneet Kamath at Citigroup Inc.
5/22/2019BarclaysBoost Price TargetOverweight$52.00 ➝ $55.00Low
i
5/21/2019Wells Fargo & CompanyReiterated RatingBuy$55.00Low
i
Rating by Elyse Greenspan at Wells Fargo & Company
4/12/2019Deutsche Bank AktiengesellschaftBoost Price TargetHold$46.00 ➝ $47.00Medium
i
4/9/2019UBS GroupBoost Price TargetNeutral ➝ Neutral$45.00 ➝ $48.00Low
i
3/19/2019Sandler O'NeillDowngradeBuy ➝ Hold$50.00Low
i
2/12/2019ArgusReiterated RatingBuyMedium
i
1/16/2019Bank of AmericaUpgradeNeutral ➝ Buy$44.06Low
i
1/8/2019Wells Fargo & CompanyReiterated RatingBuyLow
i
Rating by Elyse Greenspan at Wells Fargo & Company
1/2/2019Sandler O'NeillUpgradeHold ➝ BuyMedium
i
12/17/2018Royal Bank of CanadaLower Price TargetOutperform ➝ Outperform$57.00 ➝ $50.00Low
i
12/13/2018Wells Fargo & CompanySet Price TargetBuy$60.00Medium
i
Rating by Elyse Greenspan at Wells Fargo & Company
11/13/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$52.00 ➝ $54.00Low
i
11/2/2018Wells Fargo & CompanySet Price TargetBuy$60.00Low
i
Rating by Elyse Greenspan at Wells Fargo & Company
10/8/2018UBS GroupBoost Price TargetNeutral ➝ Neutral$48.00 ➝ $49.00Low
i
9/27/2018Wells Fargo & CompanyReiterated RatingBuy$60.00Low
i
Rating by Sean Dargan at Wells Fargo & Company
8/17/2018Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$67.00 ➝ $63.00Low
i
Rating by Andrew Kligerman at Credit Suisse Group AG
8/2/2018Sandler O'NeillReiterated RatingHold$50.00Medium
i
Rating by John Barnidge at Sandler O'Neill
7/16/2018B. RileyLower Price TargetNeutral ➝ Neutral$58.00 ➝ $50.00Low
i
7/11/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$53.00 ➝ $52.00Medium
i
7/9/2018BarclaysLower Price TargetOverweight ➝ Overweight$60.00 ➝ $57.00High
i
6/4/2018The Goldman Sachs GroupDowngradeBuy ➝ Neutral$55.91 ➝ $61.00Low
i
5/8/2018Wells Fargo & CompanyReiterated RatingBuyLow
i
Rating by Sean Dargan at Wells Fargo & Company
5/4/2018Deutsche Bank AktiengesellschaftLower Price TargetHold ➝ Hold$51.00 ➝ $48.00Medium
i
5/1/2018Wells Fargo & CompanyReiterated RatingBuyLow
i
Rating by Sean Dargan at Wells Fargo & Company
4/25/2018Credit Suisse GroupInitiated CoverageOutperform ➝ Outperform$67.00Low
i
4/5/2018Sandler O'NeillSet Price TargetHold$47.00Low
i
Rating by John Barnidge at Sandler O'Neill
4/5/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$58.00 ➝ $56.00Low
i
3/26/2018Bank of AmericaInitiated CoverageNeutral$50.00High
i
3/26/2018Atlantic SecuritiesUpgradeNeutral ➝ OverweightHigh
i
3/16/2018Wells Fargo & CompanyReiterated RatingBuy$60.00Low
i
Rating by Sean Dargan at Wells Fargo & Company
3/2/2018UBS GroupReiterated RatingNeutral ➝ Neutral$52.00 ➝ $51.00Low
i
3/1/2018Wells Fargo & CompanyReiterated RatingBuy$60.00Low
i
Rating by Sean Dargan at Wells Fargo & Company
2/23/2018Keefe, Bruyette & WoodsReiterated RatingBuy$56.00Low
i
2/14/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$59.00 ➝ $58.00High
i
2/13/2018Wells Fargo & CompanySet Price TargetBuy$60.00High
i
Rating by Sean Dargan at Wells Fargo & Company
1/31/2018The Goldman Sachs GroupReiterated RatingConviction-Buy ➝ BuyHigh
i
1/30/2018Wells Fargo & CompanyLower Price TargetBuy$61.00 ➝ $60.00High
i
Rating by Sean Dargan at Wells Fargo & Company
1/2/2018Deutsche Bank AktiengesellschaftInitiated CoverageHold$55.00Medium
i
12/14/2017Wells Fargo & CompanySet Price TargetBuy$62.00High
i
Rating by Sean Dargan at Wells Fargo & Company
11/10/2017Sandler O'NeillDowngradeBuy ➝ HoldN/A
i
11/6/2017B. RileyReiterated RatingNeutralN/A
i
Rating by R. Binner at B. Riley
11/6/2017ArgusBoost Price TargetBuy$55.00 ➝ $60.00N/A
i
11/3/2017Morgan StanleyBoost Price TargetEqual Weight$55.00 ➝ $56.00N/A
i
11/3/2017Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$56.00 ➝ $60.00N/A
i
10/18/2017Wells Fargo & CompanyReiterated RatingBuyN/A
i
Rating by Sean Dargan at Wells Fargo & Company
10/18/2017The Goldman Sachs GroupInitiated CoverageConviction-Buy$61.00N/A
i
10/10/2017(FBRC)DowngradeBuy ➝ Neutral$53.00 ➝ $52.00N/A
i
Rating by R. Binner at (FBRC)
10/5/2017Morgan StanleyBoost Price TargetEqual Weight$54.00 ➝ $55.00N/A
i
10/3/2017Wells Fargo & CompanyReiterated RatingOutperform$55.00 ➝ $60.00Low
i
Rating by Sean Dargan at Wells Fargo & Company
9/6/2017Royal Bank of CanadaReiterated RatingBuy$56.00Medium
i
9/1/2017UBS GroupReiterated RatingNeutral$57.00 ➝ $49.00Low
i
8/29/2017(FBRC)Reiterated RatingBuy$53.00Low
i
Rating by R. Binner at (FBRC)
8/28/2017Credit Suisse GroupReiterated RatingNeutral$64.00 ➝ $53.00Low
i
8/16/2017Langen McalennReiterated RatingBuyMedium
i
Rating by L. Greenberg at Langen Mcalenn
8/11/2017BarclaysLower Price TargetOverweight$67.00 ➝ $60.00Low
i
8/9/2017ArgusLower Price TargetBuy$60.00 ➝ $55.00Low
i
8/7/2017Wells Fargo & CompanyReiterated RatingBuyLow
i
Rating by Sean Dargan at Wells Fargo & Company
8/3/2017Keefe, Bruyette & WoodsReiterated RatingBuy$59.00High
i
7/24/2017JPMorgan Chase & Co.Initiated CoverageHold$78.00Low
i
Rating by Jimmy Bhullar at JPMorgan Chase & Co.
7/12/2017Wells Fargo & CompanyReiterated RatingOutperform$61.00 ➝ $63.00Low
i
Rating by Sean Dargan at Wells Fargo & Company
7/12/2017Royal Bank of CanadaReiterated RatingBuy$62.00Low
i
7/7/2017CitigroupSet Price TargetSell$51.00Low
i
Rating by Suneet Kamath at Citigroup Inc.
7/1/2017Wells Fargo & CompanyReiterated RatingBuyMedium
i
Rating by Sean Dargan at Wells Fargo & Company
5/25/2017(FBRC)UpgradeMarket Perform ➝ Outperform$54.00 ➝ $58.00Medium
i
Rating by R. Binner at (FBRC)
5/4/2017Wells Fargo & CompanyReiterated RatingBuyHigh
i
Rating by John Hall at Wells Fargo & Company
4/18/2017Wells Fargo & CompanyReiterated RatingBuyLow
i
Rating by John Hall at Wells Fargo & Company
4/3/2017JPMorgan Chase & Co.Lower Price TargetOverweight$57.00 ➝ $54.00Low
i
3/27/2017Wells Fargo & CompanyReiterated RatingBuyLow
i
Rating by John Hall at Wells Fargo & Company
3/6/2017Bank of AmericaDowngradeBuy ➝ Neutral$54.20 ➝ $54.83N/A
i
Rating by Seth Weiss at Bank of America Co.
2/21/2017CitigroupReiterated RatingSell ➝ Focus ListN/A
i
2/6/2017Royal Bank of CanadaReiterated RatingBuy$61.00N/A
i
2/5/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$65.00N/A
i
2/2/2017(FBRC)Reiterated RatingHoldN/A
i
Rating by R. Binner at (FBRC)
1/26/2017CitigroupInitiated CoverageSell$51.00N/A
i
1/23/2017Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$65.00N/A
i
12/19/2016UBS GroupReiterated RatingNeutral$54.00 ➝ $57.00N/A
i
12/9/2016Standpoint ResearchDowngradeBuy ➝ HoldN/A
i
11/28/2016(FBRC)DowngradeOutperform ➝ Market Perform$54.00N/A
i
Rating by R. Binner at (FBRC)
11/14/2016UBS GroupReiterated RatingNeutral$48.00 ➝ $54.00N/A
i
11/8/2016ArgusReiterated RatingBuy$54.00N/A
i
Rating by Jacob Kilstein at Argus
11/4/2016JPMorgan Chase & Co.Reiterated RatingBuy$51.00N/A
i
11/3/2016(FBRC)Reiterated RatingBuyN/A
i
10/8/2016Deutsche Bank AktiengesellschaftReiterated RatingHold$44.00N/A
i
10/7/2016ArgusSet Price TargetBuy$54.00N/A
i
Rating by Jacob Kilstein at Argus
10/7/2016Credit Suisse GroupInitiated CoverageNeutral$51.00N/A
i
10/6/2016Bank of AmericaSet Price TargetBuy$51.00N/A
i
Rating by Seth Weiss at Bank of America Co.
9/23/2016Wells Fargo & CompanyReiterated RatingOutperformN/A
i
9/7/2016ArgusReiterated RatingBuy$54.00N/A
i
Rating by Jacob Kilstein at Argus
9/4/2016UBS GroupReiterated RatingHold$44.00N/A
i
Rating by Suneet Kamath at UBS Group AG
8/29/2016(FBRC)Boost Price TargetOutperform$51.00 ➝ $54.00N/A
i
Rating by Randy Binner at (FBRC)
7/13/2016Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$47.00 ➝ $44.00N/A
i
Rating by Yaron Kinar at Deutsche Bank Aktiengesellschaft
7/12/2016UBS GroupReiterated RatingHold$44.00N/A
i
Rating by Suneet Kamath at UBS Group AG
7/7/2016Deutsche Bank AktiengesellschaftLower Price TargetBuy ➝ Hold$47.00 ➝ $44.00N/A
i
Rating by Yaron Kinar at Deutsche Bank Aktiengesellschaft
7/7/2016CitigroupLower Price TargetNeutral$46.00 ➝ $42.00N/A
i
7/6/2016Evercore ISIInitiated CoverageBuy$52.00N/A
i
7/6/2016JPMorgan Chase & Co.Reiterated RatingBuy$51.00N/A
i
6/27/2016Sandler O'NeillUpgradeHold ➝ BuyN/A
i
6/6/2016ArgusReiterated RatingBuyN/A
i
Rating by Jacob Kilstein at Argus
5/18/2016Bank of AmericaReiterated RatingBuyN/A
i
Rating by Seth Weiss at Bank of America Co.
5/5/2016Royal Bank of CanadaLower Price TargetOutperform$65.00 ➝ $62.00N/A
i
Rating by Eric Berg at Royal Bank of Canada
5/5/2016JPMorgan Chase & Co.Lower Price TargetOverweight$53.00 ➝ $51.00N/A
i
4/7/2016(FBRC)Reiterated RatingBuyN/A
i
Rating by Randy Binner at (FBRC)
4/3/2016Royal Bank of CanadaReiterated RatingBuyN/A
i
4/1/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$51.00N/A
i
Rating by Yaron Kinar at Deutsche Bank Aktiengesellschaft
3/16/2016UBS GroupReiterated RatingHoldN/A
i
Rating by Suneet Kamath at UBS Group AG
3/15/2016UBS GroupBoost Price TargetNeutral$44.00N/A
i
Rating by Suneet Kamath at UBS Group AG
3/14/2016Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
i
Rating by Yaron Kinar at Deutsche Bank Aktiengesellschaft
3/10/2016ArgusReiterated RatingBuy$62.00 ➝ $54.00N/A
i
(Data available from 2/27/2016 forward)
MetLife logo
MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against long-term health care services. The company serves individuals, corporations and their employees, and other institutions and their members through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and sponsoring organizations and affinity groups, as well as through career and independent agencies, bancassurance, direct marketing and e-commerce, brokers, and other third-party distribution channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
Read More

Today's Range

Now: $57.60
$56.98
$58.67

50 Day Range

MA: $52.39
$48.15
$59.56

52 Week Range

Now: $57.60
$22.85
$60.20

Volume

7,306,923 shs

Average Volume

6,056,385 shs

Market Capitalization

$50.94 billion

P/E Ratio

9.46

Dividend Yield

3.16%

Beta

1.35

Frequently Asked Questions

What sell-side analysts currently cover shares of MetLife?

The following Wall Street analysts have issued research reports on MetLife in the last twelve months: Argus, Bank of America Co., Barclays PLC, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Credit Suisse Group AG, Morgan Stanley, Piper Sandler, Royal Bank of Canada, Smith Barney Citigroup, The Goldman Sachs Group, Inc., TheStreet, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for MET.

What is the current price target for MetLife?

11 Wall Street analysts have set twelve-month price targets for MetLife in the last year. Their average twelve-month price target is $51.73, suggesting a possible downside of 10.2%. Argus has the highest price target set, predicting MET will reach $63.00 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of $32.00 for MetLife in the next year.
View the latest price targets for MET.

What is the current consensus analyst rating for MetLife?

MetLife currently has 2 hold ratings and 10 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MET will outperform the market and that investors should add to their positions of MetLife.
View the latest ratings for MET.

What other companies compete with MetLife?

How do I contact MetLife's investor relations team?

MetLife's physical mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider's listed phone number is 212-578-9500. The official website for MetLife is www.metlife.com.